You are here
Global Scope of Drug Discovery Informatics Market
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization)
In the current market scenario, there is a growing demand for discovery informatics solutions. The major factors driving the growth of the global market include the rising R&D expenditure, the increasing focus on drug discovery, and need to control the drug discovery and development cost.
The global drug discovery informatics market is projected to reach USD 2.84 Billion in 2022 from USD 1.50 Billion in 2016, at CAGR of 11.2% during forecast period. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022.
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64537381
On the other hand, the scarcity of skilled professionals, and high pricing and setup cost of informatics software are the major factors restraining the growth of this market.
The key players in the drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the global market.
- Providers drug discovery informatics solution
- Pharmaceutical companies
- Academic institutes
- Biotechnology companies
- Research institutes
- Government associations
- Contract research organizations (CROs)
North America is expected to account for the largest share of the global drug discovery informatics market. Asia Pacific is expected to register the highest growth rate from 2017 to 2022. This can be attributed to the fastest-growing APAC pharmaceutical market in the world, the availability of many qualified researchers, and the low cost of human resources and manufacturing.
Request for Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=64537381
List of Figures (25 Figures)
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom Up Approach
Figure 4 Top Down Approach
Figure 5 Drug Discovery Informatics Market, By Function, 2017 vs 2022 (USD Billion)
Figure 6 Drug Discovery Informatics Market, By Solution, 2017 vs 2022 (USD Billion)
Figure 7 Drug Discovery Informatics Market, By End User, 2017 vs 2022 (USD Billion)
Figure 8 Geographical Snapshot of Drug Discovery Informatics Market (2017-2022)
Figure 9 Rising Focus on Reducing Operational Costs—A Primary Growth Driver of The Drug Discovery Informatics Market
Figure 10 Software Segment Will Continue to Dominate The Drug Discovery Informatics Market in 2022
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.